1 | toxicity grade 35 in | | | | | | | 2 | 0.36% |
2 | low risk for medical | | | | | | | 2 | 0.36% |
3 | early stage hodgkin’s lymphoma | | | | | | | 2 | 0.36% |
4 | used to identify patients | | | | | | | 2 | 0.36% |
5 | to identify patients with | | | | | | | 2 | 0.36% |
6 | cellular therapy astct criteria | | | | | | | 2 | 0.36% |
7 | survival in patients with | | | | | | | 2 | 0.36% |
8 | identify patients with chemotherapy | | | | | | | 2 | 0.36% |
9 | patients with chemotherapy related | | | | | | | 2 | 0.36% |
10 | with chemotherapy related febrile | | | | | | | 2 | 0.36% |
11 | neutropenia who are low | | | | | | | 2 | 0.36% |
12 | who are low risk | | | | | | | 2 | 0.36% |
13 | are low risk for | | | | | | | 2 | 0.36% |
14 | according to the american | | | | | | | 2 | 0.36% |
15 | to the american society | | | | | | | 2 | 0.36% |
16 | risk for medical complications | | | | | | | 2 | 0.36% |
17 | predicts risk of severe | | | | | | | 2 | 0.36% |
18 | criteria grades severity of | | | | | | | 2 | 0.36% |
19 | risk of severe chemotherapy | | | | | | | 2 | 0.36% |
20 | ipi ripi and nccnipi | | | | | | | 2 | 0.36% |
21 | patients aged over 65 | | | | | | | 2 | 0.36% |
22 | pulmonary nodules includes both | | | | | | | 1 | 0.18% |
23 | of pulmonary nodules includes | | | | | | | 1 | 0.18% |
24 | risk of pulmonary nodules | | | | | | | 1 | 0.18% |
25 | malignancy risk of pulmonary | | | | | | | 1 | 0.18% |
26 | risk tools assess the | | | | | | | 1 | 0.18% |
27 | malignancy risk tools assess | | | | | | | 1 | 0.18% |
28 | prognostic assessment gpa estimates | | | | | | | 1 | 0.18% |
29 | nodule malignancy risk tools | | | | | | | 1 | 0.18% |
30 | assessment gpa estimates survival | | | | | | | 1 | 0.18% |
31 | gpa estimates survival in | | | | | | | 1 | 0.18% |
32 | estimates survival in patients | | | | | | | 1 | 0.18% |
33 | in patients with brain | | | | | | | 1 | 0.18% |
34 | metastases pulmonary nodule malignancy | | | | | | | 1 | 0.18% |
35 | includes both the herder | | | | | | | 1 | 0.18% |
36 | pulmonary nodule malignancy risk | | | | | | | 1 | 0.18% |
37 | nodules includes both the | | | | | | | 1 | 0.18% |
38 | twitter email admincancercalccom cancercalc | | | | | | 1 | 0.18% |
39 | both the herder and | | | | | | | 1 | 0.18% |
40 | association for supportive care | | | | | | | 1 | 0.18% |